| Immune/inflammatory factors | Type | Effect of CQ/HCQ | Citation |
| Toll-like receptors (TLRs) | TLR-3 | Inhibition | [20, 21, 44] | TLR-7 | Inhibition | [20, 21, 42–44] | TLR-8 | Inhibition | [20, 21, 42–44] | TLR-9 | Inhibition | [20, 21, 44] |
| Interferons (IFNs) | IFN-α | Inhibition | [50, 57–59] | IFN-β | Inconclusive | No data | IFN-γ | Inhibition | [50, 57–59] |
| Interleukins | IL-1 | Inhibition | [30, 61–63] | IL-2 | Inhibition | [30, 61, 65, 67, 68] | IL-6 | Inhibition | [16, 23, 30, 33, 58, 61, 70–72] | IL-10 | Facilitator | [1, 81] | IL-17 | Inhibition | [30, 57, 61] | IL-22 | Inhibition | [30, 57, 61] |
| T-cells | Th1 | Stability | [1, 81] | Th2 | Stability | [1, 81] | Th17 | Inconclusive | No data |
| CD4+ | Inconclusive | [20, 82–85] | B-cells | All B-cell subsets | Inhibition | [17, 93–95] |
| Prostaglandins (PGs) | PGs | Inhibition | [98, 99] |
| Tumor necrosis factor (TNF) | TNF-α | Inhibition | [16, 23, 30, 58, 71, 72, 109] |
| Extracellular signal-regulated kinases (ERK) | 1/2 | Inhibition | [23, 30, 110, 116] |
| Chemokines | CXCL8 | Facilitator | [1] |
| Reactive oxygen species (ROS) | — | Facilitator | [1, 29] |
| Glucose | — | Facilitator | [36, 131, 132, 134, 136, 137] |
|
|